Clinical Trials Browser

Phase 2 × Withdrawn × ceritinib × Clear all

NCT02289144 2019-07-30

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Phase 2 Withdrawn

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT02343679 2017-02-01

Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies

Phase 2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms